Advertisement

Topics

Five Prime Therapeutics Announces Executive Change

16:05 EDT 13 Mar 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, today announced that Marc Belsky, Senior Vice President a...

Other Sources for this Article

Five Prime Therapeutics, Inc.
Heather Rowe, 415-365-5737
Investor Relations
heather.rowe@fiveprime.com

NEXT ARTICLE

More From BioPortfolio on "Five Prime Therapeutics Announces Executive Change"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...